Predictors of sudden onset of sleep in Parkinson's disease

Movement Disorders : Official Journal of the Movement Disorder Society
Yvonne KörnerHans-Peter Krüger

Abstract

With respect to the ongoing discussion of "sleep attacks" in Parkinson's disease (PD), we sought to estimate the prevalence of sudden onset of sleep (SOS) with and without preceding sleepiness in PD, to identify associated factors, and to define the role of antiparkinsonian medication in SOS. We sent a questionnaire about SOS, sleep behaviour, and medication to 12,000 PD patients. The response rate was 63%, from which 6,620 complete data sets could be analysed. A total of 42.9% of our population reported SOS, 10% of whom never experienced sleepiness before the appearance of SOS (4.3% of all), and we identified the administration of all dopaminergic drugs as a risk factor for SOS. However, SOS occurred earlier after introduction of nonergoline dopamine agonists (DA) and was more strongly associated with nonergoline DA in younger patients (below 70 years) with a shorter disease duration (up to 7 years) but, actually, medication was less efficient in predicting SOS than most other factors considered such as higher age, male sex, longer disease duration, and the report of sleep disturbances. This survey strongly suggests that SOS is a multifactorial phenomenon. Some subgroups are at particular risk of experiencing SOS under nonergo...Continue Reading

References

May 1, 1967·Neurology·M M Hoehn, M D Yahr
Sep 11, 1997·The New England Journal of Medicine·W C Dement
May 20, 1998·International Journal of Legal Medicine·L A Reyner, J A Horne
Mar 25, 2000·Journal of Sleep Research·D B RyeP Gurecki
Apr 7, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·C W OlanowT Roth
Apr 25, 2000·Lancet·A H Schapira
Apr 25, 2000·Lancet·J J FerreiraO Rascol
Jun 15, 2000·Pharmacotherapy·M RyanA Wells
Aug 19, 2000·Lancet·W Pirker, S Happe
Feb 24, 2001·Journal of Neurology·P ClarenbachM Werner
Jun 8, 2001·Clinical Neuropharmacology·J L MontastrucM Lapeyre-Mestre
Jun 8, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·F Tracik, G Ebersbach
Feb 2, 2002·JAMA : the Journal of the American Medical Association·Douglas E HobsonJonathan Fleming
Mar 23, 2002·Neurology·Charles R Cantor, Matthew B Stern
Apr 10, 2002·Neurology·I ArnulfY Agid
Jun 22, 2002·BMJ : British Medical Journal·Carl Nikolaus HomannErwin Ott
Jul 12, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·J Carsten MöllerWolfgang H Oertel
Jun 5, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Sebastian PausUllrich Wüllner

❮ Previous
Next ❯

Citations

Mar 15, 2005·Journal of Neurology·J C MöllerW H Oertel
Apr 27, 2012·Journal of Neurology·Maartje LouterSebastiaan Overeem
Dec 17, 2008·Journal of Neural Transmission·Tomoko OedaHideyuki Sawada
Mar 10, 2009·Current Neurology and Neuroscience Reports·Renee Monderer, Michael Thorpy
Feb 4, 2010·Parkinsonism & Related Disorders·Ubaldo BonuccelliOlivier Rascol
Apr 10, 2008·Nature Clinical Practice. Neurology·Valérie Cochen De CockIsabelle Arnulf
Aug 22, 2008·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J C MöllerW H Oertel
Oct 12, 2010·CNS Drugs·Santiago Perez-Lloret, Olivier Rascol
Feb 10, 2006·Expert Review of Neurotherapeutics·Ubaldo Bonuccelli, Nicola Pavese
Sep 16, 2005·Expert Review of Neurotherapeutics·J Carsten Möller, Wolfgang H Oertel
Oct 18, 2007·Expert Review of Neurotherapeutics·Ubaldo Bonuccelli, Nicola Pavese
Dec 10, 2015·Expert Opinion on Drug Safety·Roberto CeravoloUbaldo Bonuccelli
Apr 26, 2006·Expert Opinion on Pharmacotherapy·Lisa SkipperEng-King Tan
Mar 8, 2008·Expert Opinion on Drug Safety·Ubaldo Bonuccelli, Roberto Ceravolo
Jul 16, 2008·Parkinsonism & Related Disorders·Jens Carsten MöllerUlrich Hemmeter
Mar 24, 2006·Sleep Medicine·Jens Carsten MöllerKarin Stiasny-Kolster
Apr 23, 2016·Expert Review of Neurotherapeutics·Hee Jin Kim, Beomseok Jeon
Oct 9, 2007·Parkinsonism & Related Disorders·Peter RiedererHeinz Reichmann
Nov 30, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Masaaki HirayamaGen Sobue
Feb 1, 2013·Yonsei Medical Journal·Hue Jung ParkDong Eon Moon
Aug 4, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·J Carsten MöllerWolfgang H Oertel
Mar 23, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Michael MachtHeiner Ellgring
Feb 24, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Charlotte MeindorfnerHans-Peter Krüger
May 31, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Imad GhorayebFrançois Tison
Feb 27, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Shen-Yang Lim, Anthony E Lang
Feb 27, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Stanley Fahn
Jan 8, 2009·Annals of Neurology·Tanya Simuni, Kapil Sethi
Jan 6, 2009·Internal Medicine Journal·A R RoseR D McEvoy
Nov 28, 2017·Current Sleep Medicine Reports·Priti Gros, Aleksandar Videnovic
Sep 1, 2014·Movement Disorders Clinical Practice·Eugene Y H Yeung, Andrea E Cavanna
Nov 4, 2015·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·N V Titova
Mar 1, 2014·Sleep Science·Daniel Gurgel Fernandes TávoraPedro Felipe Carvalhedo de Bruin
Apr 21, 2018·Current Neurology and Neuroscience Reports·Aleksandar Videnovic

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.